Amber R. Smith

2.6k total citations
15 papers, 561 citations indexed

About

Amber R. Smith is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Amber R. Smith has authored 15 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Amber R. Smith's work include RNA Research and Splicing (5 papers), RNA modifications and cancer (3 papers) and Ubiquitin and proteasome pathways (3 papers). Amber R. Smith is often cited by papers focused on RNA Research and Splicing (5 papers), RNA modifications and cancer (3 papers) and Ubiquitin and proteasome pathways (3 papers). Amber R. Smith collaborates with scholars based in United States, China and Sweden. Amber R. Smith's co-authors include Liang Xu, Fengtian He, Xufang Dai, Jiqin Lian, Lan Lan, Rebecca T. Marquez, Zhenhong Ni, Kristi L. Neufeld, Jun Qin and Min Zhang and has published in prestigious journals such as Nature Materials, Gastroenterology and Cancer Research.

In The Last Decade

Amber R. Smith

14 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amber R. Smith United States 10 383 155 153 69 61 15 561
Karl-Heinz Tomaszowski Germany 7 353 0.9× 128 0.8× 148 1.0× 83 1.2× 25 0.4× 7 504
Hui Fan China 13 483 1.3× 229 1.5× 86 0.6× 33 0.5× 71 1.2× 23 648
Maayan Roniger Israel 6 659 1.7× 156 1.0× 241 1.6× 75 1.1× 144 2.4× 6 801
Adeline Ledoux United Kingdom 8 341 0.9× 142 0.9× 126 0.8× 33 0.5× 96 1.6× 10 545
Ania Wronski United States 11 315 0.8× 76 0.5× 153 1.0× 67 1.0× 36 0.6× 13 468
Hiroe Nakamura Japan 12 182 0.5× 113 0.7× 124 0.8× 41 0.6× 38 0.6× 29 365
Dahong Zhang China 11 328 0.9× 180 1.2× 70 0.5× 28 0.4× 96 1.6× 28 492
Leilei Niu China 12 425 1.1× 215 1.4× 106 0.7× 55 0.8× 38 0.6× 21 602
Dali Zong United States 17 748 2.0× 167 1.1× 318 2.1× 43 0.6× 41 0.7× 27 873

Countries citing papers authored by Amber R. Smith

Since Specialization
Citations

This map shows the geographic impact of Amber R. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber R. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber R. Smith more than expected).

Fields of papers citing papers by Amber R. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amber R. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber R. Smith. The network helps show where Amber R. Smith may publish in the future.

Co-authorship network of co-authors of Amber R. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Amber R. Smith. A scholar is included among the top collaborators of Amber R. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amber R. Smith. Amber R. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
LeSavage, Bauer L., Aidan E. Gilchrist, Brad A. Krajina, et al.. (2024). Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids. Nature Materials. 23(8). 1138–1149. 48 indexed citations
2.
Salahudeen, Ameen A., José A. Seoane, Kanako Yuki, et al.. (2023). Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesis. Cell Reports. 42(11). 113355–113355. 8 indexed citations
3.
Lan, Lan, Jiajun Liu, Amber R. Smith, et al.. (2020). Identification and Validation of an Aspergillus nidulans Secondary Metabolite Derivative as an Inhibitor of the Musashi-RNA Interaction. Cancers. 12(8). 2221–2221. 15 indexed citations
4.
Lan, Lan, Hao Liu, Amber R. Smith, et al.. (2018). Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins. BMC Cancer. 18(1). 809–809. 28 indexed citations
5.
Li, Jian, Amber R. Smith, Rebecca T. Marquez, et al.. (2018). MicroRNA‐383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression. Molecular Carcinogenesis. 57(10). 1408–1420. 30 indexed citations
6.
Lan, Lan, Amber R. Smith, Xiaoqing Wu, et al.. (2017). Abstract 1133: Discovery of novel small molecule inhibitors of RNA-binding protein Musashi-1. Cancer Research. 77(13_Supplement). 1133–1133. 1 indexed citations
7.
Lan, Lan, Amber R. Smith, Jia Yu, et al.. (2015). Natural product (−)‐gossypol inhibits colon cancer cell growth by targeting RNA‐binding protein Musashi‐1. Molecular Oncology. 9(7). 1406–1420. 98 indexed citations
8.
Smith, Amber R., Rebecca T. Marquez, Surajit Pathak, et al.. (2015). Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression. Oncotarget. 6(14). 12558–12573. 58 indexed citations
9.
Wu, Xiaoqing, Lan Lan, Amber R. Smith, et al.. (2015). Abstract 2449: Targeting an “undruggable” RNA-binding protein: Discovery of small molecule inhibitors of HuR for novel breast cancer therapy. Cancer Research. 75(15_Supplement). 2449–2449.
10.
Li, Ling, Xinbao Hao, Jun Qin, et al.. (2014). Antibody Against CD44s Inhibits Pancreatic Tumor Initiation and Postradiation Recurrence in Mice. Gastroenterology. 146(4). 1108–1118.e12. 129 indexed citations
12.
Cheng, Ping, Zhenhong Ni, Xufang Dai, et al.. (2013). The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma cells. Cell Death and Disease. 4(2). e489–e489. 81 indexed citations
13.
Cheng, Ping, Xufang Dai, Wei Ding, et al.. (2013). The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma cells This article has been corrected since Online Publication and a corrigendum has also been published. 4 indexed citations
14.
Meng, Xiaojie, et al.. (2012). Abstract 5692: Targeted inhibition of cancer stem cells by self-assembled miRNA-nanovectors. Cancer Research. 72(8_Supplement). 5692–5692. 2 indexed citations
15.
Lian, Jiqin, Zhenhong Ni, Xufang Dai, et al.. (2011). Sorafenib Sensitizes (−)-Gossypol-Induced Growth Suppression in Androgen-Independent Prostate Cancer Cells via Mcl-1 Inhibition and Bak Activation. Molecular Cancer Therapeutics. 11(2). 416–426. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026